ARCHIVES

FDA Approves Rituxan For NHL With CHOP Therapy

This article is from The Cancer Letter archive.

Vol. 29 No. 2 | February 24, 2006

Download PDF Visit The Full Archive

Related Articles

NRSAs Renamed For Kirschstein.

June 21, 2002

Children of Male Cancer Survivors Have Highrt Risk of Birth Defects

February 25, 2011

NIH Priority To Pay 4,000 Grants, Send Summary Statements

February 2, 1996

Biotech Organization Endorses Measures On Orphan Drug Act

April 1, 1994

Panel Waffles On One Vs. Three Year Intervals For Pap Test, Agrees On when They Should Start

August 1, 1980

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005